Yang Cheng, Song Yuan, Chen Zhaowei, Yuan Xiaohan, Chen Xinhua, Ding Guohua, Guan Yang, McGrath Mary, Song Chunhua, Tong Yongqing, Wang Huiming
Renal Department, Renmin Hospital of Wuhan University, Wuhan, China.
Ultrastructure Center, Renmin Hospital of Wuhan University, Wuhan, China.
Front Genet. 2019 Jul 2;10:628. doi: 10.3389/fgene.2019.00628. eCollection 2019.
Alport syndrome (AS) is a hereditary nephropathy characterized by glomerular basement membrane lesions. AS shows a relatively rare entity with autosomal dominant gene mutation (accounts for less than 5% of AS cases) and is widely believed to be a consequence of heterozygous variants in the and genes. Until now, there have been no reports of homozygous variants in genes in AS patients, and it is scarce to detect both homozygous and heterozygous variants in a single AS pedigree. We performed genetic analysis by exome sequencing (exome-seq) in a Chinese family with AS and found four individuals harboring the c.4599T > G variant, a novel nonsense mutation that gains stop codon and results in a truncated protein. The proband and her two siblings were determined to be heterozygous, whereas their mother was homozygous. The proband satisfied the criteria for the diagnosis of AS, which included clinical manifestations of microscopic hematuria and proteinuria, and pathological features of the glomerular basement membrane (GBM), including irregular thickening and splitting. However, the other three individuals who were homozygous or heterozygous for the variant exhibited mild clinical features with isolated microscopic hematuria. In summary, we identified a novel pathogenic variant in either the heterozygous or homozygous state of the gene in a Chinese family with AS. Our results also suggest that the severity of clinical manifestations may not be entirely attributed to by the genetic variant itself in patients.
奥尔波特综合征(AS)是一种以肾小球基底膜病变为特征的遗传性肾病。AS是一种相对罕见的疾病,由常染色体显性基因突变引起(占AS病例的不到5%),普遍认为是 和 基因杂合变异的结果。到目前为止,尚无AS患者基因纯合变异的报道,在单个AS家系中同时检测到纯合和杂合变异的情况也很罕见。我们对一个患有AS的中国家系进行了外显子组测序(外显子组测序)的基因分析,发现4名个体携带 c.4599T>G变异,这是一种新的无义突变,获得了终止密码子并导致截短蛋白。先证者及其两个兄弟姐妹被确定为杂合子,而他们的母亲是纯合子。先证者符合AS的诊断标准,包括镜下血尿和蛋白尿的临床表现,以及肾小球基底膜(GBM)的病理特征,包括不规则增厚和分裂。然而,该变异的其他三名纯合或杂合个体表现出轻度临床特征,仅有镜下血尿。总之,我们在一个患有AS的中国家系中鉴定出 基因杂合或纯合状态下的一种新的致病变异。我们的结果还表明,患者临床表现的严重程度可能并非完全由 基因变异本身所致。